A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation

A cell therapy using an ex vivo-generated regulatory T-cell-enriched cell product is safe and effective for drug minimization and operational tolerance induction in living donor liver recipients with nonimmunological liver diseases. (Hepatology 2016;64:632-643).